Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

Although sarcopenia is characterized by a loss of muscle strength and skeletal muscle mass, few studies have evaluated the effect of muscle strength on hepatocellular carcinoma (HCC) patients. We evaluated the impact of sarcopenia-related factors (grip strength (GS) and the skeletal muscle index (SM...

Full description

Bibliographic Details
Main Authors: Kei Endo, Hidekatsu Kuroda, Jo Kanazawa, Takuro Sato, Yudai Fujiwara, Tamami Abe, Hiroki Sato, Youhei Kooka, Takayoshi Oikawa, Kei Sawara, Yasuhiro Takikawa
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
sarcopenia
grip strength
skeletal muscle index
hepatocellular carcinoma
lenvatinib
modified albumin-bilirubin grade
Online Access:https://www.mdpi.com/2072-6694/12/8/2146

Internet

https://www.mdpi.com/2072-6694/12/8/2146

Similar Items